OTC constipation relief has never been this simple
MONTREAL, Nov. 22 /CNW Telbec/ - MEDISCA has branched into the OTC market with its new product PEG 3350, a laxative offering a simple solution to an occasionally difficult problem.
Constipation is a problem that affects thousands of Canadians on a daily basis and can be attributed to anything from diet, social or cultural influences or side effects from a prescribed medication.
MEDISCA's PEG 3350 is an osmotic agent causing water retention which softens the stool and stimulates movement to regulate bowel habits. This mode of action displayed by PEG 3350's active ingredient, polyethylene glycol 3350, represents a safe and effective treatment for the relief of occasional constipation in adults.
Available in two packaging sizes, 255g and 510g bottles, PEG 3350 comes with its own highly accurate and built-in single dose, 17g measuring cup. A single daily dose of 17g of powder can be mixed in either water, juice, soda, coffee, or tea and clinical studies demonstrate that it may take 2 to 4 days to produce a bowel movement after starting treatment with PEG 3350.
For further details about PEG 3350 and its appropriate use, please consult the Prescribing Information that is part of the product packaging peel-off label. It is advised to consult your physician before using PEG 3350.
MEDISCA is an industry leader in the repackaging and distribution of pharmaceutical compounding supplies. We are committed to providing the highest quality of fine chemicals, Active Pharmaceutical Ingredients (API's), bases, devices and equipment.
MEDISCA Network is a provider of continuing education, formula-related technical support and consultancy services geared toward the practice of pharmacy compounding. We place quality above all else. We provide a broad range of ACPE accredited continuing education activities and venues across North America for pharmacists, pharmacy technicians, nurses and allied health professionals.
For further information: For further information: